Strategies for Streamlining Small Molecule Formulation Development When Bridging from Candidate Selection to First-in-Human Clinical Testing
Stephen Byard shares his thoughts with Pharmaceutical Technology on the strategies we use for streamlining small molecule formulation development when bridging from candidate selection to first-in-human clinical testing.
Dr Sarah Steven: 2023 Trends Article With Pharma Manufacturing
Pharma will looks for ways to streamline development in 2023, the thoughts of Dr. Sarah Stevens shared in a recent article published on Pharma Manufacturing online.
Quotient Sciences Wins Multiple Categories in 2023 CDMO Leadership Awards
Quotient Sciences is a multi-category award winner of the 2023 CDMO Leadership Awards. Now in its 12th year, the CDMO Leadership Awards recognizes superior performance by contract development and manufacturing organizations (CDMO's) across multiple categories, as voted by customers.
HPAPI supply chain: Why manufacturers should care about handling and transportation
An increasing number of drug development pipelines are turning towards the use of HPAPIs to target rare and 'undruggable' diseases. Speaking with CPHI Online, Quotient Sciences share their thoughts on the HPAPI supply chain, manufacturing and handling considerations.
Quotient Sciences Expands Formulation Development Capabilities at Nottingham, UK
An expansion of our early-phase formulation development capabilities for oral dosage forms at our Nottingham, UK, facility builds upon our existing formulation capabilities.